Back to search

Crispr Therapeutics Ltd

08882624

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

THE OLD BAKEHOUSE, ASCOT, SL5 7HL
Incorporated 07/02/2014

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Samarth Kulkarni

director · Since 27/06/2022

SENIOR EXECUTIVE

AMERICAN · UNITED STATES · Age 47

Also on 1 other board

Persons with Significant Control

Crispr Therapeutics Ag

75–100% shares

14, Baarerstrasse, Zug V8

Reg: Che-494.642.722 · The Commercial Register · A Corporation Limited By Share Ownership

Notified 06/04/2016

CompanyRankvs 1644+ SIC 72110 peers
42

Financial strength24th percentile among SIC peers · 6/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 1.99× · 16/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength6/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the director with respect to going con

Key FinancialsYear ending 31/12/2024

Turnover

£96k

Annual revenue

Net Worth

£1

Balance sheet strength

Cash

£1.0M

Cash in the bank

Profit Before Tax

£23k

Bottom line earnings

Net Current Assets

£521k

Working capital

Current Assets

£1.0M

Current Liabilities

£524k

Debtors

£33k

Admin Expenses

£96k

Operating Profit

£3

Profit After Tax

£23k

0avg. employees-1

Balance Sheet

Assets less current liabilities£521k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20241.99
20231.46

Derived from filed accounts. Not audited figures.